Stage IV Squamous Cell Lung Carcinoma AJCC v7
Also known as: Stage IV Lung Squamous Cell Carcinoma AJCC v7
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11714 | Durvalumab | 2 | Completed | 1 |
DB11836 | Sapanisertib | 2 | Completed | 1 |
DB11760 | Talazoparib | 2 | Completed | 1 |
DB15104 | Telisotuzumab vedotin | 2 | Completed | 1 |
DB11771 | Tremelimumab | 2 | Completed | 1 |
DB18442 | ABSK-091 | 2 / 3 | Completed | 1 |
DB01248 | Docetaxel | 2 / 3 | Completed | 3 |
DB11714 | Durvalumab | 2 / 3 | Completed | 1 |
DB00530 | Erlotinib | 2 / 3 | Terminated | 1 |
DB09073 | Palbociclib | 2 / 3 | Completed | 1 |
DB11972 | Rilotumumab | 2 / 3 | Terminated | 1 |
DB06186 | Ipilimumab | 3 | Active Not Recruiting | 1 |
DB06132 | Nivolumab | 3 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 3 | Active Not Recruiting | 1 |
DB18442 | ABSK-091 | Not Available | Completed | 1 |
DB01248 | Docetaxel | Not Available | Completed | 1 |
DB11714 | Durvalumab | Not Available | Completed | 1 |
DB00530 | Erlotinib | Not Available | Completed | 1 |
DB06186 | Ipilimumab | Not Available | Completed | 1 |
DB09035 | Nivolumab | Not Available | Completed | 1 |
DB09073 | Palbociclib | Not Available | Completed | 1 |
DB11972 | Rilotumumab | Not Available | Completed | 1 |
DB11760 | Talazoparib | Not Available | Completed | 1 |
DB12108 | Taselisib | Not Available | Completed | 1 |
DB11771 | Tremelimumab | Not Available | Completed | 1 |